TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Thumbnail

DOACs outperform VKAs when TAVR patients require oral anticoagulation

Hoping to shed new light on the debate between DOACs and VKAs, researchers in France examined data from more than 24,000 TAVR patients.

Thumbnail

AI model predicts diabetes risk using MRI results

The algorithm measures the amount of fat surrounding a person's heart, using that information to create an accurate diabetes risk assessment. 

Thumbnail

TAVR safe for patients with inflammatory bowel disease

Patients with Crohn’s disease and ulcerative colitis can safely undergo TAVR, researchers at the Cleveland Clinic have confirmed in a new analysis.

Permanent pacemaker implantation before or after TAVR linked to worse outcomes

Researchers tracked more than 49,000 TAVR patients, sharing their findings in Heart Rhythm

Thumbnail

Florida hospital celebrates 100th TAVR procedure

The procedure, like the hospital's first 99 TAVR cases, was a success. 

Thumbnail

Valve-in-valve TAVR outcomes ‘excellent’ after one year

Moderate to severe aortic regurgitation was seen in 0.9% of patients after 30 days and 1.3% after one year.

Tai chi could help ease depression, anxiety among stroke survivors

An eight-week tai chi course provided key benefits for older stroke survivors, researchers reported. 

How predilation affects TAVR outcomes for low-risk patients

The new study, published in Circulation: Cardiovascular Interventions, included data from nearly 500 TAVR patients.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.